Reacción #1797518

ord-a26a6cb982be419891de9650f07f65f0

Ecuación de reacción

[BH3-]C#N.[Na+]
Sodium cyanoborohydride
CC(C)(C)c1ccc(N2CCN(c3ccc(C=O)cc3)C2=O)cc1
4-(3-(4-tert-butylphenyl)-2-oxoimidazolidin-1-yl)benzaldehyde
CC(=O)O
acetic acid
O=C(O)C1CNC1
azetidine-3-carboxylic acid
CC(C)(C)c1ccc(N2CCN(c3ccc(CN4CC(C(=O)O)C4)cc3)C2=O)cc1
title product
Rendimiento 10.0%
CC(C)(C)c1ccc(N2CCN(c3ccc(CN4CC(C(=O)O)C4)cc3)C2=O)cc1
1-(4-(3-(4-tert-Butylphenyl)-2-oxoimidazolidin-1-yl)benzyl)azetidine-3-carboxylic acid
Rendimiento 10.0%

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.STIRRINGthe reaction mixture was stirred for 6 hour at room temperature
  2. 2
    Filtraciónfiltered
  3. 3
    Otropurified by reverse phase preparative HPLC (Phenomenex

Procedimiento

A mixture of 4-(3-(4-tert-butylphenyl)-2-oxoimidazolidin-1-yl)benzaldehyde (32 mg, 0.1 mmol), acetic acid (50 μl) and azetidine-3-carboxylic acid (13 mg, 0.13 mmol) in dichloromethane/MeOH (1:1, 5 mL) was stirred at room temperature for 1 hour. Sodium cyanoborohydride (3.5 mg, 0.05 mmol) was added and the reaction mixture was stirred for 6 hour at room temperature. After concentration of solvent under reduced pressure, the resulting residue was dissolved in dimethylsulfoxide, filtered and purified by reverse phase preparative HPLC (Phenomenex reverse phase Luna 5u C18(2) column, 60×21.2 mm ID, mobile phase: A=0.05% TFA in water; B=0.05% TFA in acetonitrile. The flow rate was 10-12 mL/min) to yield the title product 4 mg (10%): 1H NMR (400 MHz, CDOD3) δ 7.72 (d, 2H), 7.51-7.40 (m, 6H), 4.33 (s, 2H), 4.28 (m, 4H), 4.02 (s, 4H), 3.64 (m, 1H), 1.32 (s, 9H). MS (ESI) m/z: Calculated: 407.22; Observed: 408.00 (M++1).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07790707B2uspto-grants-2010_09